Search

Search Results

1. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review

   Adult T-cell leukemia/lymphoma (ATLL), an infrequent malignancy resultant from human T-cell lymphotropic virus type I (HTLV-1), exhibits a spectrum...

   Arash Letafati, Roben Soheili, ... Sayed-Hamidreza Mozhgani in Medical Oncology

   Article 09 September 2023
   

2. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma

   T cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is an aggressive malignancy of progenitor T cells. Despite significant improvements in...

   Yuan-hong Huang, Chao-Ling Wan, ... Sheng-li Xue in Annals of Hematology

   Article 25 May 2023
   

3. Current and emerging therapeutic strategies in adult T-cell leukemia–lymphoma

   Adult T-cell leukemia–lymphoma (ATL) is classified into four clinical subtypes: acute, lymphoma, chronic, and smoldering. Chronic ATL is further...

   Hiroo Katsuya in International Journal of Hematology

   Article 02 March 2023
   

4. Nasal Extranodal NK/T Cell Lymphoma with Orbital Involvement: A Rare Entity of Common Presentations

   Nasal Extranodal NK/T Cell Lymphoma is an aggressive tumour affecting the nasal and midline structures, causing surrounding tissue destruction as the...

   Muhammad Hazim Sharfudin, Muhammad Nasri Abu Bakar, ... Norasnieda Md Shukri in Indian Journal of Otolaryngology and Head & Neck Surgery

   Article 20 June 2024
   

5. Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation

   Patients with recurrent peripheral T-cell lymphoma (PTCL) after allogeneic hematopoietic cell transplantation (HCT) have dismal outcomes. Nodal PTCL...

   Kayoko Tao, Yoshihiro Inamoto, ... Takahiro Fukuda in International Journal of Hematology

   Article 20 February 2023
   

6. Clinicopathological and molecular genetic alterations in monomorphic–epitheliotropic intestinal T-cell lymphoma of the small intestine

   Background

   Small intestinal monomorphic–epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive T-cell lymphoma originating in the...

   Bing Zhou, Min Guo, ... Hua Hao in European Journal of Medical Research

   Article Open access 23 March 2024
   

7. Peripheral T cell lymphoma of the nasopharynx with expansion of EBV-positive B cells masquerading as an extranodal NK/T cell lymphoma, nasal type

   Epstein-Barr virus-infected B cells are found at high frequency in peripheral T cell lymphoma. Herein, we report a case involving excessive...

   Han-Na Kim, Dae Sik Kim, ... Young Hyeh Ko in Virchows Archiv

   Article 07 January 2022
   

8. Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

   Peripheral T-cell lymphomas (PTCL) other than anaplastic large-cell lymphoma are rare in children, and the role of hematopoietic stem cell...

   Olga Moser, Maud Ngoya, ... Udo Kontny in Bone Marrow Transplantation

   Article Open access 08 February 2024
   

9. Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma

   Background

   Durable remission has been observed in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) treated with chimeric...

   Elisabeth F. P. Peterse, Elisabeth J. M. Verburg-Baltussen, ... Sven L. Klijn in PharmacoEconomics - Open

   Article Open access 31 August 2023
   

10. Identification of leukocyte-lymphocyte ratio as a novel prognostic factor in Peripheral T-cell lymphoma

    Purpose

    Peripheral T-cell lymphoma (PTCL) is notorious for its heterogeneity as well as poor prognosis. High mortality remains a challenge. Our study...

    Shi-Qi Gao, Bo-Ya Lei, ... Shu Zhao in Holistic Integrative Oncology

    Article Open access 26 October 2023
    

11. Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma

    Hepatosplenic T cell lymphoma (HSTCL) is a rare and aggressive lymphoma with no standard treatment and poor treatment response. From 2001–2021, 20...

    Youngkyung Jeon, Sang Eun Yoon, ... Won Seog Kim in Annals of Hematology

    Article 16 May 2023
    

12. Predicting T-Cell Lymphoma in Children From ¹⁸F-FDG PET-CT Imaging With Multiple Machine Learning Models

    This study aimed to examine the feasibility of utilizing radiomics models derived from ¹⁸ F-FDG PET/CT imaging to screen for T-cell lymphoma in...

    Taiyu Yang, Danyan Liu, ... Feng Guan in Journal of Imaging Informatics in Medicine

    Article Open access 06 February 2024
    

13. Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies

    Background

    The risk of develo** cutaneous T cell lymphoma (CTCL) in patients using psoriasis biologics has not been well characterized. The goals of...

    Mitchell S. Davis, Riley K. Spencer, ... Wilson Liao in Dermatology and Therapy

    Article Open access 03 December 2023

14. Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy

    Purpose

    The emergence of chimeric antigen receptor (CAR) T-cell therapy fundamentally changed the management of individuals with relapsed and...

    Conrad-Amadeus Voltin, Andrea Paccagnella, ... Christine Hanoun in European Journal of Nuclear Medicine and Molecular Imaging

    Article Open access 20 December 2023
    

15. Monomorphic T-cell post-transplant lymphoproliferative disorder with features of HHV8-negative primary effusion lymphoma: an autopsy case and review of the literature

    A 67-year-old man underwent renal transplantation in his twenties. He developed refractory pleural effusion, with many large lymphocytes with severe...

    Naoki Hosaka, Mitsuharu Hashimura, ... Shin-ichi Nakatsuka in Medical Molecular Morphology

    Article Open access 23 May 2024
    

16. Immunoty** of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma

    This study aimed to explore the distribution, characteristics and prognostic value of baseline peripheral blood lymphocyte subsets in patients with...

    Fei Qi, Yuce Wei, ... Jun Zhu in Annals of Hematology

    Article 09 January 2024
    

17. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

    Follicular helper T-cell lymphomas (TFH lymphomas) were discussed in session V of the lymphoma workshop of the European Association for...

    Sarah L Ondrejka, Catalina Amador, ... Laurence de Leval in Virchows Archiv

    Article Open access 27 July 2023
    

18. Attack of the clones: a T-cell population resembling adult T-cell leukemia/lymphoma, and large granular lymphocytosis, in an HTLV-2-infected patient

    The HTLV-1 and HTLV-2 viruses, though closely genetically related, have divergent clinical impact: HTLV-1 has been causally linked with adult T-cell...

    Michael E. Kallen, Yoshine Saito, ... Rima Koka in Journal of Hematopathology

    Article 29 September 2022
    

19. Clinical characteristics and treatment of NK/T-cell lymphoma–associated HLH

    Natural killer (NK)/T-cell lymphoma–associated hemophagocytic lymphohistiocytosis (NK/T-LAHLH) is a rare and life-threatening disorder. Its clinical...

    Guangqiang Meng, **gshi Wang, ... Zhao Wang in Annals of Hematology

    Article 24 August 2022
    

20. The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma

    Aims

    To investigate the expression of polo-like kinase 1 protein (PLK1) and its phosphorylation level (p-PLK1) in extranodal NK/T cell lymphoma...

    Zhiqi Zhang, Enjie Liu, ... Wencai Li in Diagnostic Pathology

    Article Open access 30 November 2023